223 related articles for article (PubMed ID: 15952406)
1. Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus.
Garay-Sevilla ME; Regalado JC; Malacara JM; Nava LE; Wróbel-Zasada K; Castro-Rivas A; Wróbel K
J Endocrinol Invest; 2005 Mar; 28(3):223-30. PubMed ID: 15952406
[TBL] [Abstract][Full Text] [Related]
2. Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients.
Yanagisawa K; Makita Z; Shiroshita K; Ueda T; Fusegawa T; Kuwajima S; Takeuchi M; Koike T
Metabolism; 1998 Nov; 47(11):1348-53. PubMed ID: 9826211
[TBL] [Abstract][Full Text] [Related]
3. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
[TBL] [Abstract][Full Text] [Related]
4. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes.
Beisswenger PJ; Makita Z; Curphey TJ; Moore LL; Jean S; Brinck-Johnsen T; Bucala R; Vlassara H
Diabetes; 1995 Jul; 44(7):824-9. PubMed ID: 7789650
[TBL] [Abstract][Full Text] [Related]
5. Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study.
Wang X; Zhao X; Lian T; Wei J; Yue W; Zhang S; Chen Q
BMC Endocr Disord; 2021 Apr; 21(1):58. PubMed ID: 33794864
[TBL] [Abstract][Full Text] [Related]
6. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of low molecular weight advanced glycation end products in diabetic subjects.
Sharp PS; Rainbow S; Mukherjee S
Diabet Med; 2003 Jul; 20(7):575-9. PubMed ID: 12823240
[TBL] [Abstract][Full Text] [Related]
8. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
[TBL] [Abstract][Full Text] [Related]
9. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
[TBL] [Abstract][Full Text] [Related]
10. N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function.
Wagner Z; Wittmann I; Mazák I; Schinzel R; Heidland A; Kientsch-Engel R; Nagy J
Am J Kidney Dis; 2001 Oct; 38(4):785-91. PubMed ID: 11576882
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycosylation end products in patients with diabetic nephropathy.
Makita Z; Radoff S; Rayfield EJ; Yang Z; Skolnik E; Delaney V; Friedman EA; Cerami A; Vlassara H
N Engl J Med; 1991 Sep; 325(12):836-42. PubMed ID: 1875967
[TBL] [Abstract][Full Text] [Related]
12. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
[TBL] [Abstract][Full Text] [Related]
13. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
14. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.
Koschinsky T; He CJ; Mitsuhashi T; Bucala R; Liu C; Buenting C; Heitmann K; Vlassara H
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6474-9. PubMed ID: 9177242
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review.
Bos DC; de Ranitz-Greven WL; de Valk HW
Diabetes Technol Ther; 2011 Jul; 13(7):773-9. PubMed ID: 21510765
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report.
Krul-Poel YH; Agca R; Lips P; van Wijland H; Stam F; Simsek S
Cardiovasc Diabetol; 2015 Jul; 14():89. PubMed ID: 26173772
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
Chabroux S; Canouï-Poitrine F; Reffet S; Mills-Joncour G; Morelon E; Colin C; Thivolet C
Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
[TBL] [Abstract][Full Text] [Related]
18. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
[TBL] [Abstract][Full Text] [Related]
19. Methylglyoxal and Advanced Glycation End Products in Patients with Diabetes - What We Know so Far and the Missing Links.
Groener JB; Oikonomou D; Cheko R; Kender Z; Zemva J; Kihm L; Muckenthaler M; Peters V; Fleming T; Kopf S; Nawroth PP
Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):497-504. PubMed ID: 28407670
[TBL] [Abstract][Full Text] [Related]
20. Possible significance of advanced glycation end products in serum in end-stage renal disease and in late complications of diabetes.
Dolhofer-Bliesener R; Lechner B; Gerbitz KD
Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):355-61. PubMed ID: 8704053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
